Golembiewski Michael Joseph 4
4 · SEELOS THERAPEUTICS, INC. · Filed Jan 17, 2024
Insider Transaction Report
Form 4
Golembiewski Michael Joseph
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2024-01-12+24,537→ 24,537 totalExercise: $1.41Exp: 2034-01-12→ Common Stock (24,537 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on January 12, 2025, and 1/48th of the shares subject to the option shall vest monthly thereafter, subject to the Reporting Person's continued service to the Issuer through such vesting date.